| Aseracare Hospice 7660 Imperial Way, Allentown, PA, 18106 | |
| (800) 517-5734 |
News Archive
Mazor Robotics Ltd., a developer of innovative surgical robots and complementary products, today announced its Renaissance platform received U.S. FDA marketing clearance, expanding the applications of the Renaissance system to include the precise positioning of surgical instruments and implants during brain surgery.
Real-time monitoring of cancer cell processes could soon be possible thanks to nanometric scale diamonds used as biosensors.
University of North Carolina at Chapel Hill scientists have discovered a protein in the cell wall of parasites that's crucial to the molecular mechanism allowing them to move between cells, survive and cause disease.
MultiCell Technologies, Inc. has launched a new website with a fresh new look and updated information about discovery technology platforms and lead drug candidates. It also provides information to answer investors' most common questions.
A novel drug proven to reduce the risk of disease progression by 79% as well as three new European Centres of Excellence, offer new hope to patients with inoperable metastatic advanced midgut neuroendocrine cancer.
› Verified 4 days ago
| Name | Aseracare Hospice |
|---|---|
| Location | 7660 Imperial Way, Allentown, Pennsylvania |
| Hospice ID | 391712 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| Accreditation Provider | Community Health Accreditation Partner (CHAP) |
| SSA county code | 470 |
News Archive
Mazor Robotics Ltd., a developer of innovative surgical robots and complementary products, today announced its Renaissance platform received U.S. FDA marketing clearance, expanding the applications of the Renaissance system to include the precise positioning of surgical instruments and implants during brain surgery.
Real-time monitoring of cancer cell processes could soon be possible thanks to nanometric scale diamonds used as biosensors.
University of North Carolina at Chapel Hill scientists have discovered a protein in the cell wall of parasites that's crucial to the molecular mechanism allowing them to move between cells, survive and cause disease.
MultiCell Technologies, Inc. has launched a new website with a fresh new look and updated information about discovery technology platforms and lead drug candidates. It also provides information to answer investors' most common questions.
A novel drug proven to reduce the risk of disease progression by 79% as well as three new European Centres of Excellence, offer new hope to patients with inoperable metastatic advanced midgut neuroendocrine cancer.
› Verified 4 days ago
| NPI Number | 1487808200 |
| Organization Name | Hospice Preferred Choice, Inc. |
| Address | 5920 Hamilton Blvd Allentown, Pennsylvania, 18106 |
| Phone Number | (610)562-3437 |
News Archive
Mazor Robotics Ltd., a developer of innovative surgical robots and complementary products, today announced its Renaissance platform received U.S. FDA marketing clearance, expanding the applications of the Renaissance system to include the precise positioning of surgical instruments and implants during brain surgery.
Real-time monitoring of cancer cell processes could soon be possible thanks to nanometric scale diamonds used as biosensors.
University of North Carolina at Chapel Hill scientists have discovered a protein in the cell wall of parasites that's crucial to the molecular mechanism allowing them to move between cells, survive and cause disease.
MultiCell Technologies, Inc. has launched a new website with a fresh new look and updated information about discovery technology platforms and lead drug candidates. It also provides information to answer investors' most common questions.
A novel drug proven to reduce the risk of disease progression by 79% as well as three new European Centres of Excellence, offer new hope to patients with inoperable metastatic advanced midgut neuroendocrine cancer.
› Verified 4 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 92.2 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 96.6 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 93.0 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 96.6 | 97.3 |
| Patients who got timely treatment for shortness of breath | 91.7 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 97.6 | 93.3 |
News Archive
Mazor Robotics Ltd., a developer of innovative surgical robots and complementary products, today announced its Renaissance platform received U.S. FDA marketing clearance, expanding the applications of the Renaissance system to include the precise positioning of surgical instruments and implants during brain surgery.
Real-time monitoring of cancer cell processes could soon be possible thanks to nanometric scale diamonds used as biosensors.
University of North Carolina at Chapel Hill scientists have discovered a protein in the cell wall of parasites that's crucial to the molecular mechanism allowing them to move between cells, survive and cause disease.
MultiCell Technologies, Inc. has launched a new website with a fresh new look and updated information about discovery technology platforms and lead drug candidates. It also provides information to answer investors' most common questions.
A novel drug proven to reduce the risk of disease progression by 79% as well as three new European Centres of Excellence, offer new hope to patients with inoperable metastatic advanced midgut neuroendocrine cancer.
› Verified 4 days ago
| Home Health Aides | 3.2 |
| Counselors | 0.5 |
| Medical Social Workers | 1 |
| Physicians | 0.5 |
| Registered Nurses | 4.5 |
| Other Personnel | 1 |
| Total Employees | 10.7 |
|---|
News Archive
Mazor Robotics Ltd., a developer of innovative surgical robots and complementary products, today announced its Renaissance platform received U.S. FDA marketing clearance, expanding the applications of the Renaissance system to include the precise positioning of surgical instruments and implants during brain surgery.
Real-time monitoring of cancer cell processes could soon be possible thanks to nanometric scale diamonds used as biosensors.
University of North Carolina at Chapel Hill scientists have discovered a protein in the cell wall of parasites that's crucial to the molecular mechanism allowing them to move between cells, survive and cause disease.
MultiCell Technologies, Inc. has launched a new website with a fresh new look and updated information about discovery technology platforms and lead drug candidates. It also provides information to answer investors' most common questions.
A novel drug proven to reduce the risk of disease progression by 79% as well as three new European Centres of Excellence, offer new hope to patients with inoperable metastatic advanced midgut neuroendocrine cancer.
› Verified 4 days ago
| Lehigh Valley Hospice Location: 2024 Lehigh Street, Allentown, Pennsylvania, 18103 Phone: (800) 517-5734 |
| Heartland Hospice Services Inc Location: 881 Marcon Blvd Suite 3700, Allentown, Pennsylvania, 18109 Phone: (800) 517-5734 |
| Compassus - Allentown Location: 7248 Tilghman Street Suite 160, Allentown, Pennsylvania, 18106 Phone: (800) 517-5734 |
| Sacred Heart Home Care And Hospice Inc Location: 402 West Chew Street, Allentown, Pennsylvania, 18102 Phone: (800) 517-5734 |